E-viri
PDF
Odprti dostop
-
Loosdrecht, Arjan A.; Kern, Wolfgang; Porwit, Anna; Valent, Peter; Kordasti, Sharham; Cremers, Eline; Alhan, Canan; Duetz, Carolien; Dunlop, Alan; Hobo, Willemijn; Preijers, Frank; Wagner‐Ballon, Orianne; Chapuis, Nicolas; Fontenay, Michaela; Bettelheim, Peter; Eidenschink‐Brodersen, Lisa; Font, Patricia; Johansson, Ulrika; Loken, Michael R.; Marvelde, Jeroen G.; Matarraz, Sergio; Ogata, Kiyoyuki; Oelschlaegel, Uta; Orfao, Alberto; Psarra, Katherina; Subirá, Dolores; Wells, Denise A.; Béné, Marie C.; Della Porta, Matteo G.; Burbury, Kate; Bellos, Frauke; Velden, Vincent H. J.; Westers, Theresia M.; Saft, Leonie; Ireland, Robin
Cytometry. Part B, Clinical cytometry, January 2023, Letnik: 104, Številka: 1Journal Article
This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic investigation and evaluation of cytopenias of uncertain origin and suspected myelodysplastic syndromes (MDS) by the European LeukemiaNet international MDS Flow Working Group (ELN iMDS Flow WG). The WHO 2016 classification recognizes that FCM contributes to the diagnosis of MDS and may be useful for prognostication, prediction, and evaluation of response to therapy and follow‐up of MDS patients.
